Literature DB >> 30370296

Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice.

Salvatore Intagliata1, Elisa Roca1, Deborah Cosentini1, Alfredo Berruti1.   

Abstract

Entities:  

Year:  2018        PMID： 30370296      PMCID： PMC6186555          DOI： 10.21037/atm.2018.07.24

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

Review 1.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

Review 2.  Global patterns of cancer incidence and mortality rates and trends.

Authors:  Ahmedin Jemal; Melissa M Center; Carol DeSantis; Elizabeth M Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

3.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 4.  European position statement on lung cancer screening.

Authors:  Matthijs Oudkerk; Anand Devaraj; Rozemarijn Vliegenthart; Thomas Henzler; Helmut Prosch; Claus P Heussel; Gorka Bastarrika; Nicola Sverzellati; Mario Mascalchi; Stefan Delorme; David R Baldwin; Matthew E Callister; Nikolaus Becker; Marjolein A Heuvelmans; Witold Rzyman; Maurizio V Infante; Ugo Pastorino; Jesper H Pedersen; Eugenio Paci; Stephen W Duffy; Harry de Koning; John K Field
Journal:  Lancet Oncol       Date:  2017-12       Impact factor: 41.316

5.  Model-Based Eligibility for Lung Cancer Screening: Where Theory Meets Practice.

Authors:  Angela K Green; Peter Bach
Journal:  Ann Intern Med       Date:  2018-01-02       Impact factor: 25.391

6.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

7.  Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation.

Authors:  Hiroyuki Takahashi; Hisanobu Ogata; Reiko Nishigaki; David H Broide; Michael Karin
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

8.  Baseline characteristics of participants in the randomized national lung screening trial.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; Jonathan D Clapp; Kathy L Clingan; Ilana F Gareen; David A Lynch; Pamela M Marcus; Paul F Pinsky
Journal:  J Natl Cancer Inst       Date:  2010-11-22       Impact factor: 13.506

9.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

10.  Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.

Authors:  Vaibhav Kumar; Joshua T Cohen; David van Klaveren; Djøra I Soeteman; John B Wong; Peter J Neumann; David M Kent
Journal:  Ann Intern Med       Date:  2018-01-02       Impact factor: 25.391
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.